Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Novel biocompatible and biodegradable amphoteric poly(amidoamine) (
PAA
) hydrogels were designed for applications as scaffolds for tissue engineering. These hydrogels (
PAA
-AG1 and
PAA
-AG2) were obtained by polyaddition of 2,2-bisacrylamidoacetic acid with
2-methylpiperazine
and 4-aminobutyl guanidine, a bioactive molecule with a known ability to induce adhesion to cell membranes. They contain carboxylic functions in their main chain and interchain connections deriving from two different cross-linking agents: for
PAA
-AG1, a multifunctional primary amine, that is, 1,10-decanediamine; for
PAA
-AG2, a purposely synthesized
PAA
(
PAA
-NH(2)) containing pendant NH(2). Both
PAA
-AG1 and
PAA
-AG2 proved noncytotoxic and adhesive to cell membranes, as ascertained by means of cytotoxicity and proliferation tests carried out on fibroblast cell lines. Good apparent mechanical strength was also observed in the case of
PAA
-AG2, cross-linked with the
PAA
-NH(2). Both
PAA
-AG1 and
PAA
-AG2 underwent degradation tests under controlled conditions simulating the biological environments, that is, Dulbecco medium at pH 7.4 and 37 degrees C. They completely dissolved within 10 and about 40 days, respectively. In both cases, the degradation products were completely noncytotoxic. All the results of this paper point to the conclusion that agmatine-based
PAA
hydrogels are excellent substrates for cell proliferation.
...
PMID:Novel agmatine-containing poly(amidoamine) hydrogels as scaffolds for tissue engineering. 1600 67
The pH-responsive poly(amidoamine)s (PAAs) have been previously described. Whereas ISA23 enhances transfection in vitro and ISA1 promotes the cytosolic delivery of the non-permeant toxins this process shows poor efficiency. The aim of this study was to prepare and evaluate
PAA
conjugates containing the membrane disrupting peptide melittin (MLT). It was hypothesised that
PAA
conjugation would reduce the haemolytic activity of MLT at pH 7.4, however, upon delivery to tumours by the EPR effect, the polymer would uncoil in an acidic environment exposing MLT and allowing it to interact with membranes.
PAA
-MLT conjugates were prepared using MLT as a comonomer together with bis-acryloylpiperazine,
2-methylpiperazine
and bis-hydroxyethylethylenediamine (ISA1-like), or bis-acrylamidoacetic acid and
2-methylpiperazine
(ISA23-like). The melittin content of the conjugates was 6-19% (w/w). Although ISA1-MLT improved gelonin delivery compared to the parent polymer ISA1 (alpha 13-fold increase) and showed pH-dependent haemolytic activity at a polymer concentration of 0.05 mg/ml, this conjugate also displayed high haemolytic activity at pH 7.4.In contrast, ISA23-MLT like the parent compound ISA23 did not deliver gelonin. However, this conjugate could have potential as a novel polymeric anticancer conjugate due to its lack of haemolytic activity at pH 7.4 and retention of cytotoxicity.
...
PMID:Synthesis and preliminary evaluation of poly(amidoamine)-melittin conjugates as endosomolytic polymers and/or potential anticancer therapeutics. 1600 13
Biodegradable and biocompatible amphoteric poly(amido-amine) (
PAA
)-based hydrogels, containing carboxyl groups along with amino groups in their repeating unit, were considered as scaffolds for tissue engineering applications. These hydrogels were obtained by co-polymerising 2,2-bisacrylamidoacetic acid with
2-methylpiperazine
with or without the addition of different mono-acrylamides as modifiers, and in the presence of primary bis-amines as crosslinking agents. Hybrid
PAA
/albumin hydrogels were also prepared. The polymerisation reaction was a Michael-type polyaddition carried out in aqueous media. The
PAA
hydrogels were soft and swellable materials. Cytotoxicity tests were carried out by the direct contact method with fibroblast cell lines on the hydrogels both in their native state (that is, as free bases) and as salts with acids of different strength, namely hydrochloric, sulfuric, acetic and lactic acid. This was done in order to ascertain whether counterion-specific differences in cytotoxicity existed. It was found that all the amphoteric
PAA
hydrogels considered were cytobiocompatible both as free bases and salts. Selected hydrogels samples underwent degradation tests under controlled conditions simulating biological environments, i.e. Dulbecco medium at pH 7.4 and 37 degrees C. All samples degraded completely and dissolved within 10 d, with the exception of hybrid
PAA
/albumin hydrogels that did not dissolve even after eight months. The degradation products of all samples turned to be non-cytotoxic. All these results led us to conclude that
PAA
-based hydrogels have a definite potential as degradable matrices for biomedical applications.
...
PMID:Novel poly(amido-amine)-based hydrogels as scaffolds for tissue engineering. 1601 Jun 95
A poly(amidoamine) (
PAA
) copolymer with beta-cyclodextrin was obtained by polyaddition reaction of 6-deoxy-6-amino-beta-cyclodextrin (beta-CD-NH(2)) and
2-methylpiperazine
to 2,2-bis(acrylamido)acetic acid in aqueous medium. This beta-CD/
PAA
copolymer bears beta-CD units along the macromolecular chain, is water-soluble and non-cytotoxic. The complexing capacity of beta-CD/
PAA
was determined using an antiviral drug, Acyclovir, as a model of poorly water-soluble drug. Complex formation was confirmed by means of DSC and FTIR analyses. beta-CD/
PAA
can solubilize up to 11% w/w of Acyclovir notably increasing the aqueous solubility of the drug. The in vitro release studies showed the dependence of Acyclovir release rate on the solution pH. The antiviral activity of Acyclovir beta-CD/
PAA
complex was evaluated against herpes simplex virus type I in cell cultures. The Acyclovir beta-CD/
PAA
complex exhibited a higher antiviral activity than the free drug.
...
PMID:Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer. 1807 13